FDA Inspection 1266549 — Isabel Arrillaga-Romany
The FDA completed an inspection of Isabel Arrillaga-Romany on Mar 31, 2025 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional details
Clinical Investigator (CI)